Researchers unlock new insights into hard-to-treat neuroendocrine tumors

Researchers at Boston Medical Center and Dana-Farber Cancer Institute conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single cell resolution, unlocking new insights into this rare and often hard-to-treat cancer.

Pharmalittle: We’re reading about a FTC probe into GPOs, a frostbite drug, and more

Top of the morning to you, and a fine one it is. Clear blue skies are enveloping the Pharmalot campus this morning, where the official

February 15, 2024

New Report Reveals Biggest Reason Why Nurses Are Quitting

What You Should Know: – Laudio and the American Organization for Nursing Leadership announced the release of the inaugural Quantifying Nurse Manager Impact report, which

April 10, 2024

In settling fraud case, New York Medicare Advantage insurer, CEO will pay up to $100M

A western New York health insurance provider for seniors and the CEO of its medical analytics arm have agreed to pay a total of up

December 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.